The 4 Stages of Non-Small Cell Lung Cancer (NSCLC)
The stage of lung cancer tells you the location of a tumor, its size, and…
Irene Guijarro MunozSeptember 23, 2024
From Safety to Approval: RET Lung Cancer Clinical Trial Phases
The clinical trials phased approach ensures that new treatments are thoroughly evaluated before they are…
Irene Guijarro MunozSeptember 16, 2024
Getting a Second Opinion for Your Lung Cancer Diagnosis
Let's explore the importance of getting a second opinion for lung cancer, when to seek…
Irene Guijarro MunozSeptember 9, 2024
Mapping the Route: Exploring the Spread of Non-Small Cell Lung Cancer
Understanding how and why RET-positive non-small cell lung cancer (NSCLC) spreads could be the key…
Irene Guijarro MunozSeptember 3, 2024
Why Lung Cancer Biomarker Testing Matters for RET-Positive Patients
Lung cancer biomarker testing is a crucial tool for RET-positive lung cancer patients and can…
Irene Guijarro MunozAugust 19, 2024
RET-Positive Lung Cancer: Understanding its Impact on Non-Smokers
Discover how RET-positive lung cancer uniquely impacts non-smokers, including younger women, and explore cutting-edge, personalized…
Irene Guijarro MunozAugust 12, 2024
Our Path Forward
Our board member and co-founder, Ilana Stromberg, wants to share some exciting updates about The…
Irene Guijarro MunozJuly 31, 2024
The Happy Lungs Project Joins Lung Cancer Advocacy Organizations and 23andMe to Launch Lung Cancer Genetics Study to Advance Research
This study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data…
Irene Guijarro MunozJuly 29, 2024
The Happy Lungs Project Update: July 2024
We are thrilled about the ongoing investment in research supported by the Happy Lungs Project.…
Irene Guijarro MunozJuly 14, 2024
American Society of Clinical Oncology Annual Meeting 2024
The 2024 ASCO Annual Meeting, held May 31-June 4 in Chicago, IL, brought together more…
Irene Guijarro MunozJune 18, 2024
